课题基金 / 基金详情

项目摘要

项目成果

Alana L Welm的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
ADMINISTRATIVE CORE PROJECT SUMMARY The goals of the patient-derived xenograft (PDX) Development and Trial Center (PDTC) Administrative Core are to organize all elements of the PDTC and facilitate communication amongst the PDTC and PDXNet members. The Administrative Core has three Specific Aims: (1) to advance scientific endeavors and ensure achievement of specific aims, including coordination with the PDXNet; (2) to ensure oversight and compliance; and (3) to effectively manage financial resources. To accomplish these aims, the Administrative Core will facilitate and coordinate PDTC scientific activities and advisory board meetings; facilitate regularly scheduled meetings; assess progress toward specific aims; serve as a liaison between the PDTC and the NCI; maintain a shared web portal for efficient communication between PDTC members; facilitate resource allocation and monitor spending; ensure compliance with regulatory requirements; formulate NCI-required reports; develop other reports as requested by the PDTC leadership team; maintain all administrative records; and assist with preparation of publications and presentations. Consolidating this effort in the Administration Core will result in group cohesion of the PDTC and the efficient utilization and distribution of resources among the projects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of RON kinase in anti-tumor immune responses
  • 批准号:
    10198861
  • 项目类别:
  • 资助金额:
    $34.88万
  • 财政年份:
    2018
  • 负责人:
    Alana L Welm
  • 依托单位:
Role of RON kinase in anti-tumor immune responses
  • 批准号:
    10436309
  • 项目类别:
  • 资助金额:
    $34.19万
  • 财政年份:
    2018
  • 负责人:
    Alana L Welm
  • 依托单位:
Research Project 1: Identification and validation of efficacious therapies for breast cancer using patient-derived specimens
  • 批准号:
    10681677
  • 项目类别:
  • 资助金额:
    $29.68万
  • 财政年份:
    2017
  • 负责人:
    Alana L Welm
  • 依托单位:
Research Project 1: Identification and validation of efficacious therapies for breast cancer using patient-derived specimens
  • 批准号:
    10223229
  • 项目类别:
  • 资助金额:
    $44.94万
  • 财政年份:
    2017
  • 负责人:
    Alana L Welm
  • 依托单位:
海外基金